TPST Stock Analysis: Buy, Sell, or Hold?
TPST - Tempest Therapeutics, Inc. Common Stock
$1.04
-0.03 (-2.80%)
▼
5d:
-11.11%
30d:
+9.35%
90d:
-44.09%
WAIT
LOW Confidence
Analysis Updated: Aug 19, 2026 12:00 AM ET
Earnings: Aug 10, 2026
0d
Get Alerted When TPST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: TPST is down 11.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: TPST is down 11.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: TPST is currently trading at $1.04, which is considered extended relative to its 30-day fair value range of $0.88 to $1.07.
Technical Outlook: Technically, TPST is in a strong downtrend. Immediate support is located at $0.90, while resistance sits at $1.26.
Market Sentiment: TPST scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $11.00 (+928.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TPST is in a strong downtrend. Immediate support is located at $0.90, while resistance sits at $1.26.
Market Sentiment: TPST scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $11.00 (+928.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.88 -
$1.07
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
26.3%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (20/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 928.0% below Wall St target ($11.00)
- WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.88 -
$1.07
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.90
Resistance Level
$1.26
Current Trend
Strong Downtrend
Technical data as of
Aug 19, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.88
Wall Street Target
$11.00
(+928.0%)
Share & Embed Analysis
Last updated: August 20, 2026 9:56 AM ET
Data refreshes hourly during market hours. Next update: 10:56 AM
Data refreshes hourly during market hours. Next update: 10:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TPST showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Matthew Angel
BUY
231482 shares
2026-03-24
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 71 BUY |
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 35 SELL |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$108 | 53 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$125 | 50 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
10 analysts |
$138 | 65 BUY |
